ERG and prostate cancer: Prostate cancers with ERG driver mutations (n=85), mutually exclusive to SPOP (OR=0.102, 95% CI, 0.002–0.725, p=0.013; [48]), were evenly distributed among the remaining prostate cancers in MuAt clustering.